← FDA Drug Approvals (Drugs@FDA)

TEVIMBRA

BLA · Biologics License Application · Sponsor: BEIGENE · Approved 2025-03-03

Drug application

FDA Application #
BLA761380
Application type
Biologics License Application
Brand name
TEVIMBRA
Generic name
Islelizumab-Jsgr
Active ingredients
islelizumab-jsgr
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
BEIGENE
First approval
2025-03-03

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown